Skip to main content

Advertisement

Table 1 Colon cancer patients versus healthy individuals.

From: Increased serum sTRAIL levels were correlated with survival in bevacizumab-treated metastatic colon cancer

   Healthy Controls
(n = 10)
Colon Ca patients
(n = 16)
Age 51, 8 55, 18
Sex Male 8 (%80) 12(%75)
  Female 2(%20) 4(%25)
  1. Age and sex distribution of metastatic colon cancer patients (n = 16) and healthy control individuals (n = 10)